Patents by Inventor Andreas Aslund

Andreas Aslund has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230138395
    Abstract: Disclosed are pharmaceutical compositions including a plurality of nanoparticles including a compound of the following structure (1) or a pharmaceutically acceptable salt thereof. Also disclosed are methods of their use and preparation.
    Type: Application
    Filed: February 26, 2021
    Publication date: May 4, 2023
    Inventors: Peder M. ANDERSEN, Yrr MØRCH, Torsten GOESCH, Håvard SLETTA, Kristin DEGNES, Andreas ÅSLUND, Peter MOLESWORTH, Heidi JOHNSEN, Ruth SCHMID, Eugenia SANDRU, Sven Even BORGOS, Sofie SNIPSTAD, Einar SULHEIM
  • Publication number: 20200023073
    Abstract: The present invention is generally directed to improvements in the treatment of cancer and diseases in the central nervous system. A new drug delivery system is provided, method for producing it and medical uses.
    Type: Application
    Filed: September 29, 2017
    Publication date: January 23, 2020
    Inventors: YRR MORCH, RUNE HANSEN, RUTH SCHMID, HEIDI JOHNSEN, PER STENSTAD, ANDREAS ASLUND, SOFIE SNIPSTAD, SIGRID BERG, EINAR SULHEIM, CATHARINA DAVIES
  • Patent number: 9012656
    Abstract: The present invention relates to oligothiophene derivatives binding specifically to neural stem cells and neural cancer stem cells. More specifically, the invention relates to methods for detecting neural stem cells or neural cancer stem cells using said oligothiophene derivatives in a biological sample, as well as uses and kits relating thereto.
    Type: Grant
    Filed: February 15, 2011
    Date of Patent: April 21, 2015
    Assignee: Celluminova AB
    Inventors: Ola Hermansson, Peter Konradsson, Andreas Aslund, Shirin Ilkhanizadeh, Rozalyn Simon, Peter Nilsson
  • Publication number: 20120315646
    Abstract: The present invention relates to oligothiophene derivatives binding specifically to neural stem cells and neural cancer stem cells. More specifically, the invention relates to methods for detecting neural stem cells or neural cancer stem cells using said oligothiophene derivatives in a biological sample, as well as uses and kits relating thereto.
    Type: Application
    Filed: February 15, 2011
    Publication date: December 13, 2012
    Applicant: CELLUMINOVA AB
    Inventors: Ola Hermansson, Peter Konradsson, Andreas Aslund, Shirin Ilkhanizadeh, Rozalyn Simon, Peter Nilsson
  • Publication number: 20120157516
    Abstract: The present invention relates to novel substituted thiophene derivatives useful in therapy of diseases related to misfolded and aggregated proteins.
    Type: Application
    Filed: October 19, 2009
    Publication date: June 21, 2012
    Inventors: Peter Åsberg, Leif Johansson, Anna Herland, Andreas Åslund, Peter Konradsson